Zahravi Pharmaceutical Company (DZAHRAVI) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DZAHRAVI
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 | To 1401/06/31 | To 1400/06/31 |
|---|---|---|---|---|---|---|
| Operating revenue | 17,123,094 | 7,270,403 | 4,743,929 | 3,304,586 | 3,307,108 | 3,076,416 |
| Cost of operating revenue | -7,050,670 | -4,141,781 | -3,185,205 | -1,965,836 | -2,377,348 | -1,945,929 |
| Gross profit (loss) | 10,072,424 | 3,128,622 | 1,558,724 | 1,338,750 | 929,760 | 1,130,487 |
| Selling, general and administrative expenses | -1,212,908 | -736,222 | -499,140 | -332,633 | -291,607 | -203,935 |
| Other income | 75,846 | 23,286 | 4,144 | 117,884 | 3,353 | 4,961 |
| Other expenses | -197,492 | -170,049 | -66,644 | -204,120 | -84,222 | -38,083 |
| Operating profit (loss) | 8,737,870 | 2,245,637 | 997,084 | 919,881 | 557,284 | 893,430 |
| Finance costs | -525,961 | -219,738 | -308,623 | -438,937 | -436,810 | -431,779 |
| Other non-operating income and expenses | 51,395 | -43,651 | 42,078 | 8,022 | 222 | -16,652 |
| Profit (loss) from continuing operations before tax | 8,263,304 | 1,982,248 | 730,539 | 488,966 | 120,696 | 444,999 |
| Current year tax | -1,872,974 | -436,648 | -139,390 | -88,014 | -33,035 | -115,626 |
| Net profit (loss) from continuing operations | 6,390,330 | 1,545,600 | 550,074 | 166,043 | -74,610 | 329,373 |
| Net profit (loss) | 6,390,330 | 1,545,600 | 550,074 | 166,043 | -74,610 | 329,373 |
| Basic earnings (loss) per share | 601 rials | 145 rials | 172 rials | 52 rials | 27 rials | 132 rials |
| Net earnings (loss) per share, rials | 601 rials | 146 rials | 172 rials | 52 rials | -23 rials | 103 rials |
| Capital | 10,633,815 | 10,633,815 | 3,204,000 | 3,204,000 | 3,204,000 | 3,204,000 |
Reporting periods
82 periods are on file for this report, from the period ending 1388/03/31 to the period ending 1405/06/31.